Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 85 Issue 7, June 2019

Ji et al. uncovered aberrant expression of CD82 as a regulating mechanism for the proliferation and chemotherapy resistance of acute myelogenous leukemia cells. See the article on page 1024.

Editor's Focus

Top of page ⤴

Editorial

Top of page ⤴

Announcement

Top of page ⤴

Correspondence

Top of page ⤴

Comment

Top of page ⤴

Insights

Top of page ⤴

Review Article

Top of page ⤴

Population Study Article

Top of page ⤴

Clinical Research Article

Top of page ⤴

Basic Science Article

Top of page ⤴

Search

Quick links